H2020
GLORIA
Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 72 months
- Total cost
- EUR 5,855,219
- EU contribution
- EUR 5,855,219
- Participants
- 16 from 10 countries
- Topic
- H2020_PHC-17-2014
- Grant agreement
- 634886
Coordinated by Stichting Amsterdam Umc (NLNetherlands).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Stichting Amsterdam Umc | NLNetherlands | Coordinator | EUR 1,993,817 | known name (0.95) |
| Assign Clinical Research Gesmbh | ATAustria | Third party | Not stated | PIC (1.00) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Participant | EUR 188,180 | PIC (1.00) |
| Linical Spain Slu | ESSpain | Third party | Not stated | PIC (1.00) |
| Debreceni Egyetem | HUHungary | Participant | EUR 20,486 | known name (0.95) |
| Universita Degli Studi di Genova | ITItaly | Participant | EUR 156,875 | known name (0.95) |
| CR2O BV | NLNetherlands | Participant | EUR 1,909,020 | known name (0.95) |
| Linical Netherlands B.V. | NLNetherlands | Participant | EUR 317,374 | PIC (1.00) |
| Stichting Tools | NLNetherlands | Participant | EUR 96,125 | PIC (1.00) |
| Stichting Vu | NLNetherlands | Participant | EUR 0 | known name (0.95) |
| Beyondevices Lda | PTPortugal | Participant | EUR 385,806 | PIC (1.00) |
| Bluepharma - Industria Farmaceuticasa | PTPortugal | Participant | EUR 479,924 | PIC (1.00) |
| Unidade Local de Saude de Coimbra Epe | PTPortugal | Participant | EUR 198,837 | known name (0.95) |
| Universitatea de Medicina Si Farmacie Carol Davila Din Bucuresti | RORomania | Participant | EUR 86,760 | known name (0.95) |
| Narodny Ustav Reumatickych Chorob-Nurch Nird National Institute of Rheumatic Diseases | SKSlovakia | Participant | EUR 22,015 | PIC (1.00) |
| Linical Accelovance America Inc | USUnited States | Third party | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 16 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.